V ery little is known about the long-term impact of maternal inflammatory bowel disease (IBD) on the offspring's future health, and the first reported results within this area have been conflicting. It has recently been suggested by Freud et al 1 that maternal IBD during pregnancy is not associated with long-term pediatric morbidity in the offspring. Other data have, however, suggested that maternal IBD does increase the risk of long-term morbidities in the offspring. 2 The main limitations of these studies are related to methodological issues such as a limited number of children born to women with IBD, short duration of follow-up for most children, and the risk of bias.
Denmark is among the countries with the highest reported incidence rates of IBD (23 per 100,000 per year) for ulcerative colitis (UC) and 10 per 100,000 per year for Crohn's disease (CD), 3, 4 and because most patients are diagnosed in the fertile years, questions regarding reproductive matters are very frequently addressed by women with IBD. Several epidemiological studies have examined the consequences of maternal IBD during pregnancy with respect to short-term adverse birth outcomes such as preterm birth, low birth weight, intrauterine growth restriction, low Apgar score, caesarean section, and birth defects. [5] [6] [7] [8] [9] [10] Besides being concerned about short-term adverse birth outcomes, women often ask "Will I pass other diseases to my child due to my IBD?" From a biological point of view such an association cannot be ruled out. Barker et al have specifically suggested that several diseases of adult life (including coronary heart disease, hypertension, and type 2 diabetes) originate from impaired intrauterine growth and development [11] [12] [13] ; and some follow-up studies have reproduced these findings. 11 Such chronic diseases in adulthood may thus be consequences of "fetal programming," whereby an insult at a critical, sensitive period of early life has permanent effects on structure, physiology, and metabolism. Also, a maternal-offspring association between IBD and a number of other immune-mediated/inflammatory diseases are likely, as they share genetic susceptibility loci. 14 Concomitantly increasing incidences might imply common environmental risk factors and dysregulation of mucosal immune response in the pathogenesis of IBD and other immune-mediated diseases. 15 From a maternal perspective, it is clearly relevant to know whether offspring will be susceptible to chronic diseases due to maternal chronic IBD, and for physicians, it is highly relevant to be able to answer reproductive questions regarding the morbidity of the offspring of women with IBD.
We therefore aimed to examine the association between in utero exposure to maternal IBD and the long-term risk of morbidities in the offspring. Our study is based on an unselected, nationwide cohort of all births during 25 years in Denmark, and thus provides results with solid statistical power.
MATERIALS AND METHODS

Study Population and Setting
The study population comprised all live born children, born during the study period of January 1, 1989, to December 31, 2013, according to the Danish Medical Birth Registry (DMBR). The DMBR has recorded data on all births in Denmark since 1973, counting data on the mother, the birth, the child, and including the civil personal registration number of the mother and the child. 16, 17 The civil personal registration number is a digit unique identifier assigned at birth or during immigration of all Danish citizens and is used in all Danish health registries. 18 In Denmark, all citizens have free and equal access to a taxsupported health care system, and its uniform organization allowed us to use a population-based study design. In this study, mothers were linked with their children, and the children were followed from the date of birth for important health outcomes.
In 31,106 children, statistical analysis was not possible due to nonpermanent residence in Denmark, and to ensure solid information on IBD status of all mothers, we also excluded births where the mother had not been a resident of Denmark for at least 10 years before the birth of the child.
Data on Maternal IBD and Offspring Morbidity
From the Danish National Registry of Patients (DNRP), we obtained information on maternal IBD diagnosed before the childbirth. The DNRP has recorded all inpatient hospitalizations at nonpsychiatric public hospitals in Denmark since 1977, and emergency and outpatient contacts since 1995. Diagnoses in the DNRP were assigned by a code according to the eighth revision of the World Health Organisation's International Classification of Diseases (ICD-8) until the end of 1993, and the 10th revision (ICD-10) thereafter (ICD-9 was never used in Denmark). 19 From the Danish Psychiatric Central Register (DPCR), we extracted psychiatric outcomes. The DPCR was established as a nationwide registry in 1969, and the registry includes information on psychiatric hospitalizations in Denmark, including outpatient visits since 1995.
The Exposed Cohort
The exposed cohort comprised all children born alive in the study period and where the mother before the specific childbirth was discharged with a diagnosis of IBD, i.e., with affirmative UC (ICD-8 codes: 563. 19 
The Unexposed Cohort
The unexposed cohort comprised all live born children born to women without a diagnosis of IBD before the specific childbirth. Two children, born to the same mother, could thus be allocated to the group of unexposed children and the group of exposed children, respectively, if the mother was diagnosed with IBD between the 2 childbirths.
Outcome Measures
To report the child and adolescence health outcomes, the authors went through the entire ICD-8 and ICD-10 classification catalog of diseases to prioritize the relevant outcomes and ended up with 15 groups covering major nonmalignant somatic and psychiatric disease categories considered to be important and relevant concerning diseases occurring among children. When we designed the study, we agreed not to focus on malignant diseases during childhood because of an anticipated low number of malignant cases and thereby insufficient statistical power. We thus collected data on the 15 selected disease categories in the offspring of both mothers with and without IBD from the DNRP and the DPCR. In the exposed cohort, we found 6 disease categories with less than 10 child outcomes in the category, and because of the lack of statistical power, no further analyses were performed for those categories comprising non-insulin dependent diabetes mellitus (DM), parathyroid disease, polycystic ovary syndrome, systemic lupus erythematosus, multiple sclerosis, and coagulation disorders. The 9 included disease categories among the offspring were as follows: (1) DM, (2) thyroid disorders, (3) rheumatoid arthritis, (4) IBD, (5) epilepsy, (6) chronic lung disease, including asthma, (7) affective mood disorders, (8) schizophrenia/other paranoid psychoses, and (9) anxiety and personality disorders. All ICD codes are provided in the supplementary Table S1 , Supplemental Digital Content 1, http://links.lww.com/ IBD/B510.
For the occurrence of child and adolescent outcomes of DM, thyroid diseases, rheumatoid arthritis, IBD, and epilepsy, the follow-up period started from the date of childbirth and ended on December 31, 2013. For the outcomes of chronic lung disease and asthma, and the psychiatric disorders, the follow-up period started from the age of 5 years and ended on December 31, 2013, as these diseases by definition are not assigned to children aged less than 5 years of age.
Data on Covariates
We identified relevant information on known risk factors for morbidity during childhood and adolescence. From the DMBR, we extracted the following information: year of birth (divided into 5 calendar periods of 5 yr), sex of the child, mode of delivery (vaginal and cesarean section), preterm birth defined as ,37 weeks of gestation (no/yes), small for gestational age (no/ yes), 20 maternal age at birth (divided in 4 age groups), parity (1 and $2), multiple birth (no/yes), maternal smoking during pregnancy as a dichotomy variable (only collected in the registries since 1991), and maternal prepregnancy body mass index (in 4 groups, only collected in the registries since 2003). Furthermore, we collected data on relevant maternal underlying diseases in both the cohorts of women with and without IBD (see Table S1 , Supplemental Digital Content 1, http://links.lww.com/IBD/B510).
Statistical Analysis
We constructed a contingency table for the main study variables according to the exposed and the unexposed cohort. To analyze whether the offspring morbidity was different between the exposed and unexposed cohort in a standardized model, we used a multivariate Cox proportional hazard regression model with robust variance estimation, accounting for clustering of multiple children born by the same mother. The hazard ratio (HR), as the disease-specific risk estimates in a crude and adjusted model, including 95% confidence intervals (CIs), was presented. In the main analyses, we adjusted for sex of the child, year of birth, maternal age at birth, mode of delivery, multiple birth, birth order, preterm birth, and small for gestational age. Furthermore, we adjusted for maternal relevant underlying morbidity; for example, when we assessed the risk of DM in the offspring, we adjusted for maternal underlying DM, and a similar approach was used in the analyses for all other diseases in the offspring (the only exception was the analyses for IBD in the offspring where maternal IBD constituted our exposure).
In the first subanalysis, we stratified for type of maternal IBD, i.e., UC or CD and offspring morbidities were given according to this stratification in the same way as in the main analyses. Mothers in whom it was not possible to determine the type of IBD (a few were registered with both a diagnosis of UC and CD in the latest record in the DNRP, n ¼ 38) were excluded from the stratified analyses. The reference group in the subanalysis was the same as in the main analyses.
In a second sub-analysis, we restricted our data set to the period after January 1, 1991, so that we could include information on maternal smoking as a covariate in the model. A sensitivity analysis was carried out on data restricted to the first born child as a verification of the cluster analysis on the full data set. Stata Software was used for data analysis (v 14.0; StataCorp LP, College Station, TX).
Ethical Considerations
The study includes processing of personal data from national central registers and is declared to The Danish Data Protection Agency (no. 2013-41-2092) and follows rules on security and privacy. According to the Danish law, ethical review board approval or patient consent is not required for registerbased studies.
RESULTS
Between January 1, 1989, and December 31, 2013, we identified a total of 1,380,645 childbirths by 752,759 mothers. A total of 9238 children were born to mothers with IBD, and 1,371,407 children were born to mothers without IBD. The median follow-up time in the exposed cohort was 9.7 years, the 25 percentile was 4.9 years, and the 75 percentile was 15.7 years. In the unexposed group, the children were followed for a median of 13.8 years, with a 25 and 75 percentile of 7.4 years and 19.9 years, respectively. Table 1 shows the basic characteristics of exposed and unexposed children. The number of children born to women with IBD increased significantly by increasing calendar time. A total of 890 children (9.6% of all children born by IBD mothers during the study period) were born to women with IBD during 1989 to 1993 compared with a total of 2724 children (29.5%) during 2009 to 2013. Children born to women with IBD were more likely to be delivered by caesarean section than the unexposed children, and 9.2% of the children born to women with IBD were born premature, versus 6.2% in the unexposed cohort. Most mothers with IBD were in age group 30 to 39 years when they gave birth (54.0%), and most women without IBD were in the age group 20 to 29 years (49.2%) when they gave birth. In the exposed group there were more nonsmokers than in the unexposed group. Table 2 shows the crude and adjusted risk estimates for health outcomes during childhood and adolescence. We found increased adjusted risk estimates for DM, rheumatoid arthritis, lung diseases, and affective mood disorders, adjusted hazard ratio (aHR) ¼ 1.12 (95% CI, 0.75-1.68), 1.26 (95% CI, 0.99-1.60), 1.05 (95% CI, 0.91-1.21), and 1.19 (95% CI, 0.77-1.82), respectively. A more than 5-fold significantly increased risk of IBD was found in the offspring, aHR ¼ 5.68 (95% CI, 4.61-7.00). We found no increased risk of thyroid diseases, epilepsy, schizophrenia/other paranoid psychoses, and nervous conditions/personality disorders. Table 3 shows the results from the subanalyses according to health outcomes in the offspring of women with UC and CD. In women with underlying UC, the adjusted risk of IBD in the offspring was more than 4-fold increased aHR ¼ 4.63 (95% CI, 3.49-6.16). No other health outcomes were significantly increased in the offspring of women with UC. In children born to women with CD, the adjusted risk of IBD in the offspring was more than 7-fold increased aHR ¼ 7.70 (95% CI, 5.66-10.47). No other health outcomes were significantly increased in the offspring of women with CD.
In the second subanalysis, including information on maternal smoking as a covariate in the model, the results for long-term health outcomes diseases in the offspring of mothers with UC or CD were unchanged (data not shown). The sensitivity analysis on data restricted to the first born children only did not change the overall results (data not shown).
DISCUSSION
In this large nationwide study on the long-term health consequences in children born to mothers with IBD, we found an expected increased risk of IBD in the offspring. We did not find evidence of an increased risk of any other critical nonmalignant diseases during childhood and adolescence. It is an important strength of our study that we did not only focus on one single outcome as measurement of "the health in the offspring," but that we included a wide range of different diseases during childhood and adolescence, covering important somatic nonmalignant diseases and psychiatric disorders. The specific impact of maternal IBD on the health outcomes in the offspring has been of great concern for decades and has become more and more relevant because of the increasing incidence of IBD. This highlights the importance of this large population-based study, using nationwide Danish data, on more than 1.3 million childbirths over a period of 25 years.
Current publications on the impact of maternal IBD have focused on the risk of adverse short-term outcomes, which is extremely important, as preterm birth and low birth weight are strong predictors of childhood morbidity and mortality. [1] [2] [3] [4] Focus has also been given to a possible negative effect on long-term health outcomes associated with in utero exposure to IBD. The first results within this area are conflicting; they are focused only on a few different diseases in the offspring (IBD, autism spectrum disease, and asthma) and are based on a limited number of children born to women with IBD. 2 study a possible impact of maternal IBD on selected long-term health consequences in the offspring in a setting based on regional tertiary care data. Compared with the study by Freud et al, our study differs in important ways. Our study population is based on unselected nationwide data; it includes a very large number of births, and we have no risk of selection bias or information bias. Some of the main limitations in the study by Freud et al were that the number of exposed children was limited (based on 278 children), the length of follow-up for most children was not reported (the number of children followed up to an age of 18 yr was not reported), the authors could not rule out selection bias, and the risk of childhood IBD was not reported. The long-term effects on the health of offspring of women with IBD have also been studied by Dotan et al 2 based on 412 children. They concluded that maternal IBD affects long-term morbidity, specifically neurodevelopmental problems. However, the data in the study from Dotan et al 2 was based on questionnaires, and thus recall bias may have been introduced. The 2 Danish nationwide studies by Andersen et al published in 2013 and 2014 examined the risk of asthma and autism spectrum disorders in offspring with parental IBD, and they did not find an increased overall risk. 21, 22 We estimated the risk of developing overall IBD in the offspring, not specifically UC or CD, as it may be difficult to distinguish between UC and CD in younger age groups. In addition, a proportion of pediatric patients are often initially diagnosed with "IBD unclassified." The results of analyses of specifically UC or CD in the offspring would therefore be of only limited value; therefore, neither UC nor CD is performed in this study. Also, we do not give further details on, for instance, the age at time of debut of IBD in the offspring, as such information would have only little value because of the different length of follow-up for each individual in this study. We know, however, from a Danish incidence study on pediatric IBD 23 that the incidence increases rapidly after the age of 8 years. Our result of a more than 4-fold increased risk of IBD in the offspring of women with UC, and an almost 8-fold increased risk in women with CD, is in accordance with other previous publications where similar results in first-degree relatives are reported. 24, 25 Our study has several methodological strengths. The main strengths were the nationwide large-scale study approach, providing sufficient statistical power for estimating the risk of specific health outcomes. Besides having high statistical power, our results also have high validity. Data were obtained independently of the study hypothesis, data on the outcomes were obtained independently of exposure assessment, we had complete follow-up on all patients, and therefore we prevented information bias and selection bias. Furthermore, we were able to take into consideration a large number of important confounders such as effect of maternal underlying comorbidity (i.e., taking into account that, for instance, epileptic women might have increased genetic susceptibility to pass epilepsy to the offspring). The validity of the register used in this study is high. 26, 27 We had access to complete and obligatory registrations from Danish hospitals since 1979 and all outpatient visits since 1995. According to the exposure assessment (maternal diagnoses of UC and CD), the completeness of diagnoses of UC and CD has been examined using the pathology system as a reference standard, showing that of all patients with a confirmed diagnosis of UC or CD, 94% were included in the DNRP. Furthermore, the overall validity of diagnosis of UC and CD in the DNRP was 94% and 97%, respectively, in patients diagnosed at specialized departments. 28 We used the DNRP to identify diseases in the offspring, and the validity of the diagnoses is, in general, high. [28] [29] [30] [31] [32] [33] [34] [35] [36] Using nationwide registries, we also have to carefully consider the limitations of the study. For instance, we cannot rule out that some of our diagnoses on child outcomes are misclassified, but such a misclassification would most probably be nondifferential and therefore give bias toward unity. A limitation is that we did not have outcome data of the children from the general practitioners, and therefore we might have underestimated a possible negative effect of maternal IBD on the health of the children. This is, however, not a severe problem, as nearly all children suspected to be affected by diseases included in this study are expected to be referred by their general practitioners to the hospitals for confirmation of the diagnosis and future treatment. Furthermore, when examining the health effects in the offspring, it would of course be valuable to have as many years of follow-up as possible. Our follow-up period was, however, limited by the onset of the used registries. We can therefore not rule out that a negative impact of maternal IBD on the health of the offspring is diagnosed at an older age, i.e., after the end of our follow-up period. This question can only be examined in a data set with an even longer follow-up period than ours. In the exposed cohort, we found that the number of children born to women with IBD increased by increasing calendar time periods. This is most likely a reflection of the increasing incidence of both UC and CD in Denmark over the last decades, and therefore the exposed cohort also contributes to fewer years of follow-up compared with the unexposed cohort. In addition, we were unable to consider the use of medication, but even if, theoretically, we had information on IBD medication, we could not adjust for such information in our analyses as similar medication was not used in the unexposed cohort. This argument is also valid for use of biologic therapy, and furthermore, biologic therapy has only been used for a limited number of years, which prevents sufficient follow-up time in the offspring.
In this large nationwide study on the long-term consequences in the offspring of mothers with IBD, we found no evidence of an increased risk of important nonmalignant chronic diseases in the offspring, besides an expected increased risk of IBD. The results from this study are important in terms of counseling women with IBD who are contemplating pregnancy and who have questions about long-term consequences in their future offspring.
